MASH-TAG Conference 2027
MASH-TAG is a hybrid conference focused on research, clinical care, and treatment development for MASH and liver fibrosis.
The Chateaux Deer Valley
- Dates
- January 7–9, 2027
- Venue
- The Chateaux Deer Valley
- Format
- Hybrid
TL;DR
- The 2027 conference is scheduled for January 7–9 at The Chateaux Deer Valley in Park City, Utah.
- The event is described as hybrid, with sessions addressing MASH and liver fibrosis research, diagnosis, management, and treatment development.
- The organizer describes its audience as including clinicians, academic participants, pharmaceutical companies, research and development stakeholders, and healthcare professionals.
About
The conference is intended to connect clinical, academic, pharmaceutical, and research and development communities around MASH education and patient care. Its program is guided by an academic scientific advisory committee and covers clinical trial findings, trial design, pharmacology, and treatment economics.
Who you'll find in the room
Clinicians
Clinicians are among the audiences identified by the organizer.
Academic participants
The organizer identifies academia as part of the conference audience.
Pharmaceutical industry
Pharmaceutical industry participants are included in the organizer's audience description.
Research and development stakeholders
The conference is aimed in part at research and development stakeholders.
Healthcare professionals
Healthcare professionals are among the groups the conference seeks to serve.
Featured speakers
9 listedVlad Ratziu
MD, PhD
Rohit Loomba
MD, MHSc
Mary E. Rinella
MD
Quentin Anstee
MD
Samuel Klein
MD
Philip Newsome
MBBS
Mazen Noureddin
MD, MHSc
Brent Tetri
MD
Manal Abdelmalek
MD
Venue & travel
Venue
The Chateaux Deer ValleyGetting there
The venue is in Park City, Utah.
Questions people ask
5 answeredMASH-TAG Conference 2027 is scheduled for January 7–9, 2027.
The conference takes place at The Chateaux Deer Valley in Park City, Utah.
The organizer identifies clinicians, academic participants, pharmaceutical industry members, research and development stakeholders, and healthcare professionals as audiences.
It is most useful for hepatologists, clinical trialists and pharmaceutical development staff working on MASH, since the faculty includes Vlad Ratziu, Rohit Loomba, Mary E. Rinella and Quentin Anstee, and the program covers trial results, trial design and therapeutic endpoints. Clinicians outside liver disease or general audiences would get less from it, because the content is focused on MASH and liver fibrosis research and drug development, though the hybrid format lets remote attendees follow along.
Attendees at academic and clinical medical meetings usually wear business casual, such as slacks and collared shirts or blouses, with a blazer for some sessions. Park City in early January is cold and snowy, so warm outerwear and waterproof footwear for getting to and from The Chateaux Deer Valley are practical.
Related events
Find more events with this kind of reach.
We score 300,000+ B2B events by decision-maker density, so you can find the next one for your ICP.